First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Bergstedt, Winnie ^a   Tingskov, Pernille N ^b   Thierry Carstensen, Birgit ^b   Hoff, Søren T ^b   Aggerbeck, Henrik ^b   Thomsen, Vibeke O ^b   Andersen, Peter ^b   Andersen, Aase B ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; REAGENT;

ADULT; ARTICLE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG SAFETY; FEMALE; FERMENTATION; HUMAN; HUMAN EXPERIMENT; HYPOPIGMENTATION; INFLUENZA; INJECTION SITE COLORATION; INJECTION SITE CONTUSION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; LABORATORY DIAGNOSIS; LACTOCOCCUS; MALE; MYCOBACTERIUM TUBERCULOSIS; NAUSEA; NORMAL HUMAN; PRURITUS; SENSITIZATION; SIDE EFFECT; SKIN TEST; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; HUMANS; INTERFERON-GAMMA; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TUBERCULIN TEST; TUBERCULOSIS;

ANIMALIA; LACTOCOCCUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77955331504     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011277     Document Type: Article

References (14)

1. Menzies D, Pai M, Comstock G (2007) Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146: 340-54.
2. Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149: 177-84.
3. Andersen P, Munk ME, Pollock JM, Doherty TM (2000) Specific immune-based diagnosis of tuberculosis. Lancet 356: 1099-104.
4. Brock I, Weldingh K, Leyten EM, Arend SM, Ravn P, et al. (2004) Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 42: 2379-87.
5. Huebner RE, Schein MF, Bass JB Jr (1993) The tuberculin skin test. Clin Infect Dis 17: 968-75.
6. Snider DE Jr (1982) The tuberculin skin test. Am Rev Respir Dis 125: 108-18.
7. Aggerbeck H, Madsen SM (2006) Safety of ESAT-6. Tuberculosis 86: 363-73.
8. Arend SM, Franken WP, Aggerbeck H, Prins C, van Dissel JT, et al. (2008) Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection. Tuberculosis 88: 249-61.
9. Lillebaek T, Bergstedt W, Tingskov PN, Thierry-Carstensen B, Aggerbeck H, et al. (2009) Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique. Tuberculosis 89: 158-62.
10. Renshaw PS, Lightbody KL, Veverka V, Muskett FW, Kelly G, et al. (2005) Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 24: 2491-8.
11. Skjot RL, Oettinger T, Rosenkrands I, Ravn P, Brock I, et al. (2000) Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 68: 214-20.
12. van Pinxteren LA, Ravn P, Agger EM, Pollock J, Andersen P (2000) Diagnosis of tuberculosis based on the two specific antigens ESAT-6 and CFP10. Clin Diagn Lab Immunol 7: 155-60.
13. Thompson NJ, Glassroth JL, Snider DE Jr, Farer LS (1979) The booster phenomenon in serial tuberculin testing. Am Rev Respir Dis 119: 587-97.
14. Arend SM, van Meijgaarden KE, de Boer K, de Palou EC, van Soolingen D, et al. (2002) Tuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis 186: 1797-807